Research supported by the National Institutes of Health (NIH), a Stanley and Linda Sher research grant and Georgetown Lombardi Comprehensive Cancer Center, a NCI-designated Comprehensive Cancer Center in Washington, DC, shows how scientists at Georgetown Lombardi have decoded a chain of molecules that are critical for the growth and survival of pancreatic ductal adenocarcinoma (PDAC)—the most common and also the most lethal form of pancreatic cancer.
Today, complete surgical removal of the tumor remains the only chance for cure. However, an estimated 80% to 90% of all patients have disease that is surgically incurable at the time of clinical presentation. Read more . . .